Wei-Kai Chuang

ORCID: 0000-0002-4934-5427
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Radiomics and Machine Learning in Medical Imaging
  • Head and Neck Cancer Studies
  • Breast Cancer Treatment Studies
  • Artificial Intelligence in Healthcare and Education
  • COVID-19 diagnosis using AI
  • Metastasis and carcinoma case studies
  • Esophageal Cancer Research and Treatment
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Cancer Treatment and Pharmacology
  • Lung Cancer Diagnosis and Treatment
  • Salivary Gland Tumors Diagnosis and Treatment
  • Breast Implant and Reconstruction
  • Polyomavirus and related diseases
  • Fungal Infections and Studies
  • Breast Lesions and Carcinomas

Taipei Medical University-Shuang Ho Hospital
2022-2024

National Yang Ming Chiao Tung University
2024

Koo Foundation Sun Yat-Sen Cancer Center
2018-2022

Background: This study examined the current American Joint Committee on Cancer (AJCC) 8th edition staging system and proposes a new classification for nasopharyngeal carcinoma (NPC). Methods: One thousand four hundred eighteen newly diagnosed patients with NPC without distant metastasis from 1995 through 2010 were identified. Patients treated three-dimensional conformal radiotherapy (3D-CRT) used as training cohort. Based T N categories of AJCC 7th system, recursive partitioning analysis...

10.21037/tro.2020.02.01 article EN Therapeutic Radiology and Oncology 2020-03-01

A 54-year-old woman presented to an outpatient clinic with a recurrence of triple-negative breast cancer and multiple bone metastases. The patient had large mass lesion 10 cm on the sternum. She received immune checkpoint inhibitors pembrolizumab taxane. Initially, responded excellently treatment, but stopped for grade IV skin toxicity ulcerative wounds over bilateral leg trunk. lesions abated following administration antibiotics oral prednisolone two months. After that, she was referred...

10.3390/diagnostics14080850 article EN cc-by Diagnostics 2024-04-19

Recurrences are frequent in nasopharyngeal carcinoma (NPC) despite high remission rates with treatment, leading to considerable morbidity. This study aimed develop a prediction model for NPC survival by harnessing both pre- and post-treatment magnetic resonance imaging (MRI) radiomics conjunction clinical data, focusing on 3-year progression-free (PFS) as the primary outcome. Our comprehensive approach involved retrospective MRI data collection of 276 eligible patients from three independent...

10.1007/s10278-024-01109-7 article EN Deleted Journal 2024-04-30

10.1016/j.ijrobp.2024.07.1411 article EN International Journal of Radiation Oncology*Biology*Physics 2024-09-27

PURPOSE Dose escalation may only be suitable for some patients with esophageal cancer (EC) undergoing concurrent chemoradiotherapy (CCRT). This study aimed to identify specific subgroups of whom dose was most beneficial. MATERIALS AND METHODS Between January 2008 and December 2022, 187 EC underwent CCRT; 94 received high-dose (HD) radiotherapy (RT; >64.8 Gy), 93 low-dose (LD) RT. We developed a model on the basis clinical radiomic features compare predicted survival probabilities...

10.1200/po-24-00555 article EN JCO Precision Oncology 2024-12-01

This study aimed to analyze the long-term outcomes of hypofractionated whole-breast irradiation (WBI) (HF-WBI) compared with those conventionally fractionated WBI (CF-WBI) for early breast cancer treated breast-conservation surgery (BCS) and adjuvant in Taiwan.This included patients at our institution between 2012 2016. All received BCS (pT1-2, pN0, M0) through one two treatment schemes. Propensity score matching analysis was conducted create comparable cohorts. The major result is...

10.1016/j.jfma.2022.01.015 article EN cc-by-nc-nd Journal of the Formosan Medical Association 2022-01-29

Post-operative radiotherapy (PMRT) has shown to reduce locoregional recurrence and increase disease-free survival overall in high risk breast cancer patients, combination with chemotherapy or hormone therapy. For stage II cancer, PMRT was still under discussion. Current NCCN guideline recommend N1 patients receive PMRT. This study aims evaluate the impact of on different subtype. Between 1990 2013, there were 1252 Stage (T1-2 one three positive) treated by mastectomy at Koo Foundation Sun...

10.1016/j.ijrobp.2018.07.1606 article EN other-oa International Journal of Radiation Oncology*Biology*Physics 2018-10-19
Coming Soon ...